About one million people in the United States are living with Parkinson’s Disease.
Levodopa is the most effective drug available, but the drug can cause side effects, and after several years, the effectiveness can wane.
With higher doses, patients may develop dyskinesia, or involuntary, erratic movements.
Now, a new drug that’s currently in clinical trials may reduce these unpleasant side effects while lengthening the time patients have relief of their symptoms.
Andrea Ludema explains in today’s Healthy Living.